XVIVO’s patents for the heart preservation fluid approved in the US and Europe
XVIVO’s patent for the heart preservation fluid has been approved in the US and Europe. Canada has already approved this patent. XVIVO has also previously received a patent for the heart evaluation equipment in Europe, Australia, Canada and China. The review of the patent application for the heart evaluation equipment is in its final stages in the US. Together these patents strengthen XVIVO’s position in the heart transplantation field on all major markets in the world.XVIVO has two main patents in the field of heart transplantation. The first of these covers the preservation fluid that is